Thymidylate synthase is a predictor for response and resistance in hepatic artery infusion chemotherapy.
第一作者:
M,Kornmann
第一单位:
Department of General Surgery, University of Ulm, Germany.
作者:
医学主题词
成年人(Adult);老年人(Aged);抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);结直肠肿瘤(Colorectal Neoplasms);用药计划表(Drug Administration Schedule);抗药性, 肿瘤(Drug Resistance, Neoplasm);表柔比星(Epirubicin);女(雌)性(Female);氟尿苷(Floxuridine);氟尿嘧啶(Fluorouracil);肝动脉(Hepatic Artery);人类(Humans);输注, 动脉内(Infusions, Intra-Arterial);醛氢叶酸(Leucovorin);肝肿瘤(Liver Neoplasms);男(雄)性(Male);中年人(Middle Aged);米托蒽醌(Mitoxantrone);聚合酶链反应(Polymerase Chain Reaction);试验预期值(Predictive Value of Tests);预后(Prognosis);RNA, 信使(RNA, Messenger);存活率(Survival Rate);胸苷酸合酶(Thymidylate Synthase);转录, 遗传(Transcription, Genetic)
DOI
10.1016/s0304-3835(97)00220-6
PMID
9310257
发布时间
2019-07-20
- 浏览11
Cancer letters
29-35页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



